Financials Eastman Chemical Company

Equities

EMN

US2774321002

Diversified Chemicals

Real-time Estimate Cboe BZX 10:14:25 2024-04-30 am EDT 5-day change 1st Jan Change
96.31 USD -1.06% Intraday chart for Eastman Chemical Company -0.30% +7.45%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 10,779 13,588 16,255 9,768 10,645 11,447 - -
Enterprise Value (EV) 1 16,357 18,642 20,955 14,426 14,943 15,746 15,663 15,597
P/E ratio 14.5 x 28.7 x 19.3 x 12.8 x 12 x 12.9 x 11 x 10.5 x
Yield 3.18% 2.66% 2.34% 3.77% 3.54% 3.34% 3.52% 3.76%
Capitalization / Revenue 1.16 x 1.6 x 1.55 x 0.92 x 1.16 x 1.22 x 1.15 x 1.09 x
EV / Revenue 1.76 x 2.2 x 2 x 1.36 x 1.62 x 1.67 x 1.58 x 1.48 x
EV / EBITDA 8.18 x 10.4 x 9.64 x 7.94 x 9.37 x 8.71 x 7.91 x 7.33 x
EV / FCF 15.2 x 17.4 x 19.7 x 18.7 x 27.4 x 23.8 x 27.2 x 17.7 x
FCF Yield 6.6% 5.75% 5.08% 5.35% 3.65% 4.19% 3.67% 5.64%
Price to Book 1.81 x 2.26 x 2.73 x - 1.93 x 1.97 x 1.8 x 1.65 x
Nbr of stocks (in thousands) 136,000 135,500 134,440 119,940 118,513 117,599 - -
Reference price 2 79.26 100.3 120.9 81.44 89.82 97.34 97.34 97.34
Announcement Date 1/30/20 1/28/21 1/27/22 1/26/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 9,273 8,473 10,476 10,580 9,210 9,420 9,917 10,511
EBITDA 1 2,000 1,790 2,173 1,816 1,595 1,809 1,980 2,128
EBIT 1 1,389 1,216 1,635 1,339 1,097 1,283 1,459 1,587
Operating Margin 14.98% 14.35% 15.61% 12.66% 11.91% 13.62% 14.71% 15.1%
Earnings before Tax (EBT) 1 902 530 1,082 977 1,087 1,064 1,243 1,281
Net income 1 759 478 857 793 894 889.1 1,043 1,087
Net margin 8.19% 5.64% 8.18% 7.5% 9.71% 9.44% 10.52% 10.34%
EPS 2 5.480 3.500 6.250 6.350 7.490 7.556 8.820 9.282
Free Cash Flow 1 1,079 1,072 1,064 772 546 660.5 575.6 879.5
FCF margin 11.64% 12.65% 10.16% 7.3% 5.93% 7.01% 5.8% 8.37%
FCF Conversion (EBITDA) 53.95% 59.89% 48.96% 42.51% 34.23% 36.52% 29.07% 41.32%
FCF Conversion (Net income) 142.16% 224.27% 124.15% 97.35% 61.07% 74.29% 55.19% 80.92%
Dividend per Share 2 2.520 2.670 2.830 3.070 3.180 3.254 3.423 3.657
Announcement Date 1/30/20 1/28/21 1/27/22 1/26/23 2/1/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 2,694 2,714 2,784 2,709 2,373 2,412 2,324 2,267 2,207 2,310 2,360 2,409 2,347 2,462 2,505
EBITDA 1 458 487 591 450 288 424 455 376 340 401 461.2 494.8 451.7 473.2 500.4
EBIT 1 336 366 469 333 171 283 336 256 222 274 334.6 359.8 317.6 345.4 363.9
Operating Margin 12.47% 13.49% 16.85% 12.29% 7.21% 11.73% 14.46% 11.29% 10.06% 11.86% 14.18% 14.94% 13.53% 14.03% 14.53%
Earnings before Tax (EBT) 1 529 287 381 281 28 194 269 199 425 214 279.2 307 270.2 286.5 331.5
Net income 1 378 235 256 301 1 134 272 178 310 165 235.2 259.5 228.8 241 279
Net margin 14.03% 8.66% 9.2% 11.11% 0.04% 5.56% 11.7% 7.85% 14.05% 7.14% 9.97% 10.77% 9.75% 9.79% 11.14%
EPS 2 2.810 1.800 2.030 2.460 0.0100 1.120 2.270 1.490 2.610 1.390 1.994 2.192 1.933 2.010 2.260
Dividend per Share 2 0.7600 0.7600 0.7600 0.7600 0.7900 0.7900 0.7900 - 0.8100 0.8100 0.8100 0.8067 0.8157 0.8552 0.8552
Announcement Date 1/27/22 4/28/22 7/28/22 10/27/22 1/26/23 4/27/23 7/27/23 10/26/23 2/1/24 4/25/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 5,578 5,054 4,700 4,658 4,298 4,299 4,216 4,150
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 2.789 x 2.823 x 2.163 x 2.565 x 2.695 x 2.377 x 2.13 x 1.95 x
Free Cash Flow 1 1,079 1,072 1,064 772 546 661 576 880
ROE (net income / shareholders' equity) 16.8% 14% 20.7% - 14.4% 15.8% 16.9% 17.3%
ROA (Net income/ Total Assets) 6.17% 5.23% 7.68% - 5.21% 5.94% 6.54% 6.86%
Assets 1 12,293 9,142 11,164 - 17,165 14,967 15,940 15,853
Book Value Per Share 2 43.80 44.30 44.20 - 46.50 49.50 54.00 59.00
Cash Flow per Share 2 10.90 10.70 11.80 7.810 11.50 11.10 15.90 14.80
Capex 1 425 383 555 611 828 754 854 854
Capex / Sales 4.58% 4.52% 5.3% 5.78% 8.99% 8% 8.61% 8.12%
Announcement Date 1/30/20 1/28/21 1/27/22 1/26/23 2/1/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
21
Last Close Price
97.34 USD
Average target price
107 USD
Spread / Average Target
+9.95%
Consensus
  1. Stock Market
  2. Equities
  3. EMN Stock
  4. Financials Eastman Chemical Company